Human-like atherosclerosis in minipigs: A new model for detection and treatment of vulnerable plaques

Danish Medical Bulletin

Volumn 57, Issue 7, 2010, Pages

  Thim, Troels ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CORONARY SYNDROME; ANGIOSCOPY; AORTA; ARTICLE; ATHEROGENIC DIET; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL CALCIFICATION; CAROTID ARTERY; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY ATHEROTHROMBOSIS; DIAGNOSTIC VALUE; DISEASE PREDISPOSITION; EUROPE; HEART INJURY; HUMAN; HYPERCHOLESTEROLEMIA; INTIMA; INTRAVASCULAR ULTRASOUND; ISCHEMIC HEART DISEASE; MICROVASCULATURE; NEAR INFRARED SPECTROSCOPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL COHERENCE TOMOGRAPHY; STABLE ANGINA PECTORIS; STENOSIS; SWINE; THERMOGRAPHY; THROMBOSIS; UNITED STATES; ANIMAL; CALCINOSIS; CORONARY BLOOD VESSEL; DISEASE COURSE; DISEASE MODEL; HEART MUSCLE ISCHEMIA; MINIPIG; PATHOLOGY; REVIEW;

ANIMALS; ATHEROSCLEROSIS; CALCINOSIS; CORONARY VESSELS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HUMANS; MYOCARDIAL ISCHEMIA; SWINE; SWINE, MINIATURE;

EID: 77954576412     PISSN: 16039629     EISSN: 16039629     Source Type: Journal    
DOI: None     Document Type: Article

References (141)

1. WHO. The global burden of disease: 2004 update. ISBN 978 92 4 156371 0. 2004
2. Thygesen K, Alpert JS, White HD et al. Universal definition of myocardial infarction. Circulation 2007;116:2634-2653.
3. Thim T, Hagensen MK, Bentzon JF et al. From vulnerable plaque to atherothrombosis. J Intern Med 2008;263:506-516.
4. Kannel WB, Cupples LA, D'Agostino RB. Sudden death risk in overt coronary heart disease: the Framingham Study. Am Heart J 1987;113:799-804.
5. Fox CS, Evans JC, Larson MG et al. Temporal trends in coronary heart disease mortality and sudden cardiac death from 1950 to 1999: the Framingham Heart Study. Circulation 2004;110:522-527.
6. Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol 2006;47:C7-12.
7. Tabas I, Williams KJ, Boren J. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 2007;116:1832-1844.
8. Barger AC, Beeuwkes R, III, Lainey LL et al. Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. N Engl J Med 1984;310:175-177.
9. Kolodgie FD, Gold HK, Burke AP et al. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 2003;349:2316-2325.
10. Stary HC, Chandler AB, Glagov S et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1994;89:2462-2478.
11. Stary HC, Chandler AB, Dinsmore RE et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1995;92:1355-1374.
12. Virmani R, Kolodgie FD, Burke AP et al. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000;20:1262-1275.
13. Stary HC. Natural history and histological classification of atherosclerotic lesions: an update. Arterioscler Thromb Vasc Biol 2000;20:1177-1178.
14. Isner JM, Donaldson RF, Fortin AH et al. Attenuation of the media of coronary arteries in advanced atherosclerosis. Am J Cardiol 1986;58:937-939.
15. Houtkamp MA, de Boer OJ, van der Loos CM et al. Adventitial infiltrates associated with advanced atherosclerotic plaques: structural organization suggests generation of local humoral immune responses. J Pathol 2001;193:263-269.
16. Glagov S, Weisenberg E, Zarins CK et al. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987;316:1371-1375.
17. Hermiller JB, Tenaglia AN, Kisslo KB et al. In vivo validation of compensatory enlargement of atherosclerotic coronary arteries. Am J Cardiol 1993;71:665-668.
18. Motoyama S, Sarai M, Harigaya H et al. Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol 2009;54:49-57.
19. Schaar JA, Muller JE, Falk E et al. Terminology for high-risk and vulnerable coronary artery plaques. Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini, Greece. Eur Heart J 2004;25:1077-1082.
20. Sherman CT, Litvack F, Grundfest W et al. Coronary angioscopy in patients with unstable angina pectoris. N Engl J Med 1986;315:913-919.
21. Kubo T, Imanishi T, Takarada S et al. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. J Am Coll Cardiol 2007;50:933-939.
22. Farb A, Burke AP, Tang AL et al. Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation 1996;93:1354-1363.
23. Falk E. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J 1983;50:127-134.
24. Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation 1985;71:699-708.
25. Fernandez-Ortiz A, Badimon JJ, Falk E et al. Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. J Am Coll Cardiol 1994;23:1562-1569.
26. Mann J, Davies MJ. Mechanisms of progression in native coronary artery disease: role of healed plaque disruption. Heart 1999;82:265-268.
27. Burke AP, Kolodgie FD, Farb A et al. Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression. Circulation 2001;103:934-940.
28. Haft JI, Haik BJ, Goldstein JE et al. Development of significant coronary artery lesions in areas of minimal disease. A common mechanism for coronary disease progression. Chest 1988;94:731-736.
29. Bruschke AV, Kramer JR, Jr., Bal ET et al. The dynamics of progression of coronary atherosclerosis studied in 168 medically treated patients who underwent coronary arteriography three times. Am Heart J 1989;117:296-305.
30. Kolodgie FD, Burke AP, Skorija KS et al. Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis. Arterioscler Thromb Vasc Biol 2006;26:2523-2529.
31. Cheruvu PK, Finn AV, Gardner C et al. Frequency and distribution of thin-cap fibroatheroma and ruptured plaques in human coronary arteries: a pathologic study. J Am Coll Cardiol 2007;50:940-949.
32. Felton CV, Crook D, Davies MJ et al. Relation of plaque lipid composition and morphology to the stability of human aortic plaques. Arterioscler Thromb Vasc Biol 1997;17:1337-1345.
33. Katz SS, Shipley GG, Small DM. Physical chemistry of the lipids of human atherosclerotic lesions. Demonstration of a lesion intermediate between fatty streaks and advanced plaques. J Clin Invest 1976;58:200-211.
34. Lundberg B. Chemical composition and physical state of lipid deposits in atherosclerosis. Atherosclerosis 1985;56:93-110.
35. Davies MJ. Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995. Circulation 1996;94:2013-2020.
36. van der Wal AC, Becker AE, van der Loos CM et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994;89:36-44.
37. Burke AP, Farb A, Malcom GT et al. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997;336:1276-1282.
38. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995;92:657-671.
39. Pasterkamp G, Schoneveld AH, van der Wal AC et al. Relation of arterial geometry to luminal narrowing and histologic markers for plaque vulnerability: the remodeling paradox. J Am Coll Cardiol 1998;32:655-662.
40. Burke AP, Kolodgie FD, Farb A et al. Morphological predictors of arterial remodeling in coronary atherosclerosis. Circulation 2002;105:297-303.
41. McCarthy MJ, Loftus IM, Thompson MM et al. Angiogenesis and the atherosclerotic carotid plaque: an association between symptomatology and plaque morphology. J Vasc Surg 1999;30:261-268.
42. Virmani R, Kolodgie FD, Burke AP et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 2005;25:2054-2061.
43. Barger AC, Beeuwkes R, III. Rupture of coronary vasa vasorum as a trigger of acute myocardial infarction. Am J Cardiol 1990;66:41G-43G.
44. Zhang Y, Cliff WJ, Schoefl GI et al. Immunohistochemical study of intimal microvessels in coronary atherosclerosis. Am J Pathol 1993;143:164-172.
45. Sangiorgi G, Rumberger JA, Severson A et al. Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. J Am Coll Cardiol 1998;31:126-133.
46. Ehara S, Kobayashi Y, Yoshiyama M et al. Spotty calcification typifies the culprit plaque in patients with acute myocardial infarction: an intravascular ultrasound study. Circulation 2004;110:3424-3429.
47. Beckman JA, Ganz J, Creager MA et al. Relationship of clinical presentation and calcification of culprit coronary artery stenoses. Arterioscler Thromb Vasc Biol 2001;21:1618-1622.
48. Mauriello A, Sangiorgi G, Fratoni S et al. Diffuse and active inflammation occurs in both vulnerable and stable plaques of the entire coronary tree: a histopathologic study of patients dying of acute myocardial infarction. J Am Coll Cardiol 2005;45:1585-1593.
49. Colombo A, Iakovou I. Plaque sealing--a concept waiting for support. Int J Cardiovasc Intervent 2005;7:72-74.
50. Sano K, Kawasaki M, Ishihara Y et al. Assessment of vulnerable plaques causing acute coronary syndrome using integrated backscatter intravascular ultrasound. J Am Coll Cardiol 2006;47:734-741.
51. Botnar RM, Stuber M, Kissinger KV et al. Noninvasive coronary vessel wall and plaque imaging with magnetic resonance imaging. Circulation 2000;102:2582-2587.
52. Kim WY, Astrup AS, Stuber M et al. Subclinical coronary and aortic atherosclerosis detected by magnetic resonance imaging in type 1 diabetes with and without diabetic nephropathy. Circulation 2007;115:228-235.
53. Ueda Y, Ohtani T, Shimizu M et al. Assessment of plaque vulnerability by angioscopic classification of plaque color. Am Heart J 2004;148:333-335.
54. Stefanadis C, Diamantopoulos L, Vlachopoulos C et al. Thermal heterogeneity within human atherosclerotic coronary arteries detected in vivo: A new method of detection by application of a special thermography catheter. Circulation 1999;%20;99:1965-1971.
55. Stefanadis C, Toutouzas K, Tsiamis E et al. Increased local temperature in human coronary atherosclerotic plaques: an independent predictor of clinical outcome in patients undergoing a percutaneous coronary intervention. J Am Coll Cardiol 2001;37:1277-1283.
56. Mintz GS, Nissen SE, Anderson WD et al. American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2001;37:1478-1492.
57. Yamagishi M, Terashima M, Awano K et al. Morphology of vulnerable coronary plaque: insights from follow-up of patients examined by intravascular ultrasound before an acute coronary syndrome. J Am Coll Cardiol 2000;35:106-111.
58. Rodriguez-Granillo GA, Garcia-Garcia HM, Mc Fadden EP et al. In vivo intravascular ultrasound-derived thin-cap fibroatheroma detection using ultrasound radiofrequency data analysis. J Am Coll Cardiol 2005;46:2038-2042.
59. Schaar JA, de Korte CL, Mastik F et al. Characterizing vulnerable plaque features with intravascular elastography. Circulation 2003;108:2636-2641.
60. Schaar JA, van der Steen AF, Mastik F et al. Intravascular palpography for vulnerable plaque assessment. J Am Coll Cardiol 2006;47:C86-C91.
61. Prati F, Regar E, Mintz GS et al. Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis. Eur Heart J 2009
62. Wang J, Geng YJ, Guo B et al. Near-infrared spectroscopic characterization of human advanced atherosclerotic plaques. J Am Coll Cardiol 2002;39:1305-1313.
63. Moreno PR, Lodder RA, Purushothaman KR et al. Detection of lipid pool, thin fibrous cap, and inflammatory cells in human aortic atherosclerotic plaques by near-infrared spectroscopy. Circulation 2002;105:923-927.
64. Regar E, Hennen B, Grube E et al. First-In-Man application of a miniature self-contained intracoronary magnetic resonance probe. A multi-centre safety and feasibility trial. EuroIntervention 2006;2:77-83.
65. Spagnoli LG, Mauriello A, Sangiorgi G et al. Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. JAMA 2004;292:1845-1852.
66. Dalager S, Paaske WP, Kristensen IB et al. Artery-related differences in atherosclerosis expression: implications for atherogenesis and dynamics in intima-media thickness. Stroke 2007;38:2698-2705.
67. Trostdorf F, Buchkremer M, Harmjanz A et al. Fibrous cap thickness and smooth muscle cell apoptosis in high-grade carotid artery stenosis. Eur J Vasc Endovasc Surg 2005;29:528-535.
68. Gronholdt ML, Nordestgaard BG, Bentzon J et al. Macrophages are associated with lipid-rich carotid artery plaques, echolucency on B-mode imaging, and elevated plasma lipid levels. J Vasc Surg 2002;35:137-145.
69. Davies MJ, Richardson PD, Woolf N et al. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J 1993;69:377-381.
70. Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 1998;97:916-931.
71. Monahan TS, Owens CD. Risk factors for lower-extremity vein graft failure. Semin Vasc Surg 2009;22:216-226.
72. Qiao JH, Walts AE, Fishbein MC. The severity of atherosclerosis at sites of plaque rupture with occlusive thrombosis in saphenous vein coronary artery bypass grafts. Am Heart J 1991;122:955-958.
73. Falk E. Fatal atherosclerosis developed in less than 4 years in an aortocoronary vein graft in a hyperlipidemic patient. Acta Pathol Microbiol Immunol Scand A 1984;92:73-75.
74. Gerrity RG, Natarajan R, Nadler JL et al. Diabetes-induced accelerated atherosclerosis in swine. Diabetes 2001;50:1654-1665.
75. Xi S, Yin W, Wang Z et al. A minipig model of high-fat/high-sucrose diet-induced diabetes and atherosclerosis. International Journal of Experimental Pathology 2004;85:223-231.
76. Plump AS, Smith JD, Hayek T et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 1992;71:343-353.
77. Zhang SH, Reddick RL, Piedrahita JA et al. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992;258:468-471.
78. Bach Knudsen KE, Canibe N. Changes in pig plasma lipids to dietary cholesterol, source and level of dietary fibre and caecal infusion of propionate. Commission of the European Communities 1994:123-130.
79. Ando H, Tsuruoka S, Yamamoto H et al. Regulation of cholesterol 7alpha-hydroxylase mRNA expression in C57BL/6 mice fed an atherogenic diet. Atherosclerosis 2005;178:265-269.
80. Rapacz J, Hasler-Rapacz J, Taylor KM et al. Lipoprotein mutations in pigs are associated with elevated plasma cholesterol and atherosclerosis. Science 1986;234:1573-1577.
81. Prescott MF, McBride CH, Hasler-Rapacz J et al. Development of complex atherosclerotic lesions in pigs with inherited hyper-LDL cholesterolemia bearing mutant alleles for apolipoprotein B. Am J Pathol 1991;139:139-147.
82. Prescott MF, Hasler-Rapacz J, von Linden-Reed J et al. Familial hypercholesterolemia associated with coronary atherosclerosis in swine bearing different alleles for apolipoprotein B. Ann N Y Acad Sci 1995;748:283-292.
83. Hasler-Rapacz J, Prescott MF, von Linden-Reed J et al. Elevated concentrations of plasma lipids and apolipoproteins B, C-III, and E are associated with the progression of coronary artery disease in familial hypercholesterolemic swine. Arterioscler Thromb Vasc Biol 1995;15:583-592.
84. Hasler-Rapacz J, Ellegren H, Fridolfsson AK et al. Identification of a mutation in the low density lipoprotein receptor gene associated with recessive familial hypercholesterolemia in swine. Am J Med Genet 1998;76:379-386.
85. Behler RH, Nichols TC, Zhu H et al. ARFI imaging for noninvasive material characterization of atherosclerosis. Part II: toward in vivo characterization. Ultrasound Med Biol 2009;35:278-295.
86. Grunwald KA, Schueler K, Uelmen PJ et al. Identification of a novel Arg-->Cys mutation in the LDL receptor that contributes to spontaneous hypercholesterolemia in pigs. J Lipid Res 1999;40:475-485.
87. Schwartz RS, Murphy JG, Edwards WD et al. Restenosis after balloon angioplasty. A practical proliferative model in porcine coronary arteries. Circulation 1990;82:2190-2200.
88. Schwartz RS, Huber KC, Murphy JG et al. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol 1992;19:267-274.
89. Maeng M, Olesen PG, Emmertsen NC et al. Time course of vascular remodeling, formation of neointima and formation of neoadventitia after angioplasty in a porcine model. Coron Artery Dis 2001;12:285-293.
90. Badimon JJ, Ortiz AF, Meyer B et al. Different response to balloon angioplasty of carotid and coronary arteries: effects on acute platelet deposition and intimal thickening. Atherosclerosis 1998;140:307-314.
91. Pels K, Labinaz M, Hoffert C et al. Adventitial angiogenesis early after coronary angioplasty: correlation with arterial remodeling. Arterioscler Thromb Vasc Biol 1999;19:229-238.
92. Fingerle J, Johnson R, Clowes AW et al. Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery. Proc Natl Acad Sci U S A 1989;86:8412-8416.
93. Lam JY, Lacoste L, Bourassa MG. Cilazapril and early atherosclerotic changes after balloon injury of porcine carotid arteries. Circulation 1992;85:1542-1547.
94. Angelini GD, Bryan AJ, Williams HM et al. Time-course of medial and intimal thickening in pig venous arterial grafts: relationship to endothelial injury and cholesterol accumulation. J Thorac Cardiovasc Surg 1992;103:1093-1103.
95. Zou Y, Dietrich H, Hu Y et al. Mouse model of venous bypass graft arteriosclerosis. Am J Pathol 1998;153:1301-1310.
96. Zwolak RM, Kirkman TR, Clowes AW. Atherosclerosis in rabbit vein grafts. Arteriosclerosis 1989;9:374-379.
97. Hanyu M, Kume N, Ikeda T et al. VCAM-1 expression precedes macrophage infiltration into subendothelium of vein grafts interposed into carotid arteries in hypercholesterolemic rabbits--a potential role in vein graft atherosclerosis. Atherosclerosis 2001;158:313-319.
98. Dietrich H, Hu Y, Zou Y et al. Rapid development of vein graft atheroma in ApoE-deficient mice. Am J Pathol 2000;157:659-669.
99. Lardenoye JH, de Vries MR, Lowik CW et al. Accelerated atherosclerosis and calcification in vein grafts: a study in APOE*3 Leiden transgenic mice. Circ Res 2002;91:577-584.
100. Kumar A, Lindner V. Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler Thromb Vasc Biol 1997;17:2238-2244.
101. Ivan E, Khatri JJ, Johnson C et al. Expansive arterial remodeling is associated with increased neointimal macrophage foam cell content: the murine model of macrophage-rich carotid artery lesions. Circulation 2002;105:2686-2691.
102. Hainaud P, Bonneau M, Pignaud G et al. The calcium inhibitor SR33805 reduces intimal formation following injury of the porcine carotid artery. Atherosclerosis 2001;154:301-308.
103. Kockx MM, De Meyer GR, Jacob WA et al. Triphasic sequence of neointimal formation in the cuffed carotid artery of the rabbit. Arterioscler Thromb 1992;12:1447-1457.
104. Ishii A, Vinuela F, Murayama Y et al. Swine model of carotid artery atherosclerosis: experimental induction by surgical partial ligation and dietary hypercholesterolemia. AJNR Am J Neuroradiol 2006;27:1893-1899.
105. Shi ZS, Feng L, He X et al. Vulnerable plaque in a Swine model of carotid atherosclerosis. AJNR Am J Neuroradiol 2009;30:469-472.
106. Bentzon JF, Weile C, Sondergaard CS et al. Smooth muscle cells in atherosclerosis originate from the local vessel wall and not circulating progenitor cells in ApoE knockout mice. Arterioscler Thromb Vasc Biol 2006;26:2696-2702.
107. Bentzon JF, Sondergaard CS, Kassem M et al. Smooth muscle cells healing atherosclerotic plaque disruptions are of local, not blood, origin in apolipoprotein E knockout mice. Circulation 2007;116:2053-2061.
108. Bayes-Genis A, Campbell JH, Carlson PJ et al. Macrophages, myofibroblasts and neointimal hyperplasia after coronary artery injury and repair. Atherosclerosis 2002;163:89-98.
109. Reis ED, Roque M, Dansky H et al. Sulindac inhibits neointimal formation after arterial injury in wild-type and apolipoprotein E-deficient mice. Proc Natl Acad Sci U S A 2000;97:12764-12769.
110. Carmeliet P, Moons L, Stassen JM et al. Vascular wound healing and neointima formation induced by perivascular electric injury in mice. Am J Pathol 1997;150:761-776.
111. Chiesa G, Di MC, Colombo N et al. Development of a lipid-rich, soft plaque in rabbits, monitored by histology and intravascular ultrasound. Atherosclerosis 2001;156:277-287.
112. Virmani R, Farb A, Carter AJ et al. Pathology of radiation-induced coronary artery disease in human and pig. Cardiovasc Radiat Med 1999;1:98-101.
113. Alp NJ, West NE, Arnold N et al. Increased intimal hyperplasia in experimental vein graft stenting compared to arterial stenting: comparisons in a new rabbit model of stent injury. Cardiovasc Res 2002;56:164-172.
114. Heck AF, Hasuo M, Furuse M et al. Distribution of serum protein labeled with Evans blue in the walls of extra-and intracranial blood vessels of the cat. Atherosclerosis 1976;23:227-238.
115. Christensen BC, Chemnitz J, Tkocz I et al. Repair in arterial tissue. The role of endothelium in the permeability of a healing intimal surface. Vital staining with Evans blue and silver-staining of the aortic intima after a single dilatation trauma. Acta Pathol Microbiol Scand A 1977;85:297-310.
116. Fogarty T, Cranley J, Krause R et al. A method for extraction of arterial emboli and thrombi. Surg Gynecol Obstet 1963;116:241-244.
117. van Beusekom HM, Whelan DM, Hofma SH et al. Long-term endothelial dysfunction is more pronounced after stenting than after balloon angioplasty in porcine coronary arteries. J Am Coll Cardiol 1998;32:1109-1117.
118. Lundholm L, Jacobsson L, Brattsand R et al. Influence of nicotinic acid, niceritrol and beta-pyridylcarbinol on experimental hyperlipidemia and atherosclerosis in mini-pigs. Atherosclerosis 1978;29:217-239.
119. Jacobsson L, Lundholm L. Experimental atherosclerosis in hypercholesterolemic mini-pigs. Regression of cholesterol ester accumulation in aorta and coronary arteries after treatment with clofibrate, beta-pyridylcarbinol or a normo-lipidemic diet. Atherosclerosis 1982;45:129-148.
120. Jacobsson L. Comparison of experimental hypercholesterolemia and atherosclerosis in Gottingen mini-pigs and Swedish domestic swine. Atherosclerosis 1986;59:205-213.
121. Jacobsson L. Influence of clofibrate on the plasma lipoprotein pattern and on the lipid content and protein and collagen synthesis in atherosclerotic coronary arteries and abdominal aorta from hypercholesterolemic mini-pigs. Atherosclerosis 1987;63:173-180.
122. Jacobsson L. Comparison of experimental hypercholesterolemia and atherosclerosis in male and female mini-pigs of the Gottingen strain. Artery 1989;16:105-117.
123. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
124. Kobari Y, Koto M, Tanigawa M. Regression of diet-induced atherosclerosis in Gottingen miniature swine. Lab Anim 1991;25:110-116.
125. Schwartz RS, Edelman E, Virmani R et al. Drug-Eluting Stents in Preclinical Studies: Updated Consensus Recommendations for Preclinical Evaluation. Circ Cardiovasc Intervent 2008;1:143-153.
126. Nair A, Kuban BD, Obuchowski N et al. Assessing spectral algorithms to predict atherosclerotic plaque composition with normalized and raw intravascular ultrasound data. Ultrasound Med Biol 2001;27:1319-1331.
127. Nair A, Kuban BD, Tuzcu EM et al. Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation 2002;106:2200-2206.
128. Serruys PW, Garcia-Garcia HM, Buszman P et al. Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque. Circulation 2008;118:1172-1182.
129. Granada JF, Wallace-Bradley D, Win HK et al. In vivo plaque characterization using intravascular ultrasound-virtual histology in a porcine model of complex coronary lesions. Arterioscler Thromb Vasc Biol 2007;27:387-393.
130. Virmani R, Nakazawa G. Animal models and virtual histology. Arterioscler Thromb Vasc Biol 2007;27:1666-1668.
131. Mitani Y, Ohashi H, Sawada H et al. In vivo plaque composition and morphology in coronary artery lesions in adolescents and young adults long after Kawasaki disease: a virtual histology-intravascular ultrasound study. Circulation 2009;119:2829-2836.
132. Garcia-Garcia HM, Gonzalo N, Tanimoto S et al. Characterization of edge effects with paclitaxel-eluting stents using serial intravascular ultrasound radiofrequency data analysis: the BETAX (BEside TAXus) Study. Rev Esp Cardiol 2008;61:1013-1019.
133. Granada JF, Raizner AE, Kaluza GL. Animal models and virtual histology. Arterioscler Thromb Vasc Biol 2007;27:1667-1668.
134. Kragel AH, Reddy SG, Wittes JT et al. Morphometric analysis of the composition of atherosclerotic plaques in the four major epicardial coronary arteries in acute myocardial infarction and in sudden coronary death. Circulation 1989;80:1747-1756.
135. Nakazawa G, Finn AV, Virmani R. Virtual histology: does it add anything? Heart 2007;93:897-898.
136. Burke AP, Joner M, Virmani R. IVUS-VH: a predictor of plaque morphology? Eur Heart J 2006;27:1889-1890.
137. Kragel AH, Roberts WC. Composition of atherosclerotic plaques in the coronary arteries in homozygous familial hypercholesterolemia. Am Heart J 1991;121:210-211.
138. Granada JF, Kaluza GL, Wilensky RL et al. Porcine models of coronary atherosclerosis and vulnerable plaque for imaging and interventional research. EuroIntervention 2009;5:140-148.
139. Cullen P, Baetta R, Bellosta S et al. Rupture of the atherosclerotic plaque: does a good animal model exist? Arterioscler Thromb Vasc Biol 2003;23:535-542.
140. Rekhter MD. How to evaluate plaque vulnerability in animal models of atherosclerosis? Cardiovasc Res 2002;54:36-41.
141. Schwartz SM, Galis ZS, Rosenfeld ME et al. Plaque rupture in humans and mice. Arterioscler Thromb Vasc Biol 2007;27:705-713.